About this Medicine article
Prognostic Impact of P21/waf1/cip1 in Colorectal Cancer by Thomas K. Zirbes; Stephan E. Baldus; Stefan P. Moenig; Silke Nolden; Doreen Kunze; Sven T. Shafizadeh; Paul M. Schneider; Juergen Thiele; Arnulf H. Hoelscher; Hans P. Dienes is a Medicine article available to read on EtoBox.
In addition to the tumor suppressor gene p53, Cyclin Dependent Kinases (CDK) are well known to influence the cell cycle in normal human tissues and various neoplasias as well. The purpose of our present study was to evaluate the expression of the CDK-inhibitor p21/waf1/cip1 in colorectal cancer with special emphasis on the prognostic impact. Between 1985 and 1991, 294 patients (median age, 65 years) underwent surgical operative therapy for colorectal cancer. Formalin-fixed and paraffin-embedded tumor specimens were investigated. For immunohistochemistry the Catalysed Reporter Deposition (CARD) technique was performed. The survival propability was calculated and possible prognostic risk factors were tested using multivariate analysis. The p21/ waf1/cip1 staining pattern was positive in 197 (67%) specimens and negative in 97 (33%) samples. No significant correlation could been calculated between p21/waf1/cip1 expression and other variables such as age, sex, WHO-Classification, localisation, grading, TNM-classification or UICCstage. Patients with a positive staining reaction had a significantly better survival (p < 0.0052). Moreover, p21/waf1/cip1 was shown to be an independent progno
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Thomas K. Zirbes; Stephan E. Baldus; Stefan P. Moenig; Silke Nolden; Doreen Kunze; Sven T. Shafizadeh; Paul M. Schneider; Juergen Thiele; Arnulf H. Hoelscher; Hans P. Dienes
- Publisher
- John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley; Research Square; Test accounts (ISSN 0020-7136)
- Published
- 2000
- Language
- EN
- Field
- Medicine (Health Sciences)